Free to follow every thread. No paywall, no dead ends.
Influenza: the story on HearLore | HearLore
Influenza
In the winter of 1918, a virus emerged that would kill more people in a single year than the Black Death had killed in four years, yet for decades, its true nature remained a mystery. This was the Spanish flu, an influenza pandemic that claimed an estimated 50 million lives worldwide, disproportionately targeting healthy young adults rather than the elderly. The virus, an H1N1 strain of influenza A, spread with terrifying speed across the globe, carried by soldiers returning from the First World War and the chaotic movement of populations during a time of global conflict. Unlike typical flu seasons where the elderly and very young bear the brunt of mortality, the 1918 pandemic saw death rates spike among those aged 20 to 40, a phenomenon that baffled medical professionals of the era. The initial wave in the first half of 1918 was relatively mild, resembling past flu outbreaks, but the second wave later that year was a biological catastrophe, causing lungs to fill with fluid and turning healthy young people into victims of their own immune systems. The respiratory route of transmission was clearly identified during this crisis, proving that influenza was caused by a filterable agent, not a bacterium as previously believed, but the scientific community remained divided on the exact cause for another decade. This pandemic marked the beginning of a new era in virology, where the invisible enemy was finally understood to be a virus, setting the stage for future research that would eventually lead to the discovery of the influenza virus itself in 1933.
The Architecture of a Microscopic Enemy
The influenza virus is a master of disguise, possessing a segmented genome that allows it to evolve with alarming speed and evade human immune defenses. Composed of eight segments of negative-sense, single-stranded RNA, the virus encodes ten major proteins, including the critical hemagglutinin and neuraminidase proteins that sit on its surface like keys to a lock. These proteins determine the virus's subtype, with influenza A viruses classified by combinations of 16 hemagglutinin types and 11 neuraminidase types, creating a vast array of potential variants. The virus particle, or virion, is pleomorphic, varying from spherical to filamentous shapes, and is encased in a lipid bilayer envelope derived from the host cell membrane. Inside this envelope, the viral RNA is bound to nucleoproteins and wrapped in a matrix protein that provides structural reinforcement. The virus's life cycle begins when its hemagglutinin proteins bind to sialic acid receptors on the surface of a host cell, allowing the virus to enter and hijack the cell's machinery to replicate. This process involves the virus snatching 5' caps from cellular RNA to prime its own mRNA synthesis, a unique mechanism that allows it to produce viral proteins efficiently. The virus also encodes non-structural proteins like NS1 and PB1-F2 that suppress the host's immune response, ensuring the virus can replicate unchecked. This genetic flexibility is the source of both the virus's power and its danger, as it allows the virus to mutate rapidly and escape the immunity generated by previous infections or vaccinations.
What caused the 1918 Spanish flu pandemic and how many people died?
The 1918 Spanish flu pandemic was caused by an H1N1 strain of influenza A and claimed an estimated 50 million lives worldwide. This virus spread with terrifying speed across the globe, carried by soldiers returning from the First World War and the chaotic movement of populations during a time of global conflict.
How does the influenza virus evolve and why must vaccines be updated annually?
Influenza viruses evolve through two distinct mechanisms called antigenic drift and antigenic shift, which together create a perpetual cycle of seasonal epidemics and occasional pandemics. This constant evolution is why flu vaccines must be updated annually, as the virus is always one step ahead of human defenses.
When did the first influenza pandemic occur and what was the first flu vaccine licensed date?
The first convincing record of an influenza pandemic dates back to 1510, beginning in East Asia before spreading to North Africa and then Europe. The first influenza vaccine was licensed in 1945 in the United States, and influenza A virus was identified as the agent responsible for human influenza in 1933.
Who is most affected by influenza and when does flu season peak in the northern hemisphere?
Influenza viruses infect 5 to 15 percent of the global population each year, causing 3 to 5 million cases of severe illness and accounting for 290,000 to 650,000 deaths due to respiratory illness. In temperate regions, the number of influenza cases peaks during the winter season, from October to May in the northern hemisphere.
What are the primary methods to prevent and treat influenza infections?
Influenza can be prevented and treated through a combination of vaccination, antiviral drugs, and non-pharmaceutical interventions, but the effectiveness of these measures depends on the timing and the specific strain of the virus. Annual vaccination is the primary and most effective way to prevent influenza and influenza-associated complications, especially for high-risk groups.
Influenza viruses evolve through two distinct mechanisms, antigenic drift and antigenic shift, which together create a perpetual cycle of seasonal epidemics and occasional pandemics. Antigenic drift is a gradual accumulation of mutations in the virus's genome, particularly in the hemagglutinin and neuraminidase genes, allowing the virus to evade pre-existing antibody-mediated immunity. This process is especially common in the hemagglutinin protein, where just a few amino acid changes in the head region can constitute antigenic drift, resulting in novel strains that can infect people who have been vaccinated or infected with previous strains. Antigenic shift, on the other hand, is a sudden, drastic change in the virus's antigen, usually hemagglutinin, that occurs when two or more influenza viruses infect the same cell and reassort their genome segments. This process is most common among influenza A viruses and can create a novel strain that is capable of human-to-human transmission, leading to pandemics. Pigs, bats, and quails serve as potential mixing vessels for reassortment because they have receptors for both mammalian and avian influenza viruses, allowing for the creation of hybrid progeny. The Global Influenza Surveillance and Response System of the World Health Organization tests millions of specimens annually to monitor the spread and evolution of influenza viruses, ensuring that vaccines are updated to match the circulating strains. This constant evolution is why flu vaccines must be updated annually, as the virus is always one step ahead of human defenses.
The Global Toll of a Seasonal Plague
In a typical year, influenza viruses infect 5 to 15 percent of the global population, causing 3 to 5 million cases of severe illness and accounting for 290,000 to 650,000 deaths due to respiratory illness. The burden of influenza is disproportionately borne by high-risk groups, including young children, the elderly, and people with chronic health conditions such as asthma, cardiovascular disease, and diabetes. In temperate regions, the number of influenza cases peaks during the winter season, from October to May in the northern hemisphere and from May to October in the southern hemisphere, while in tropical and subtropical regions, influenza can occur year-round. The seasonality of influenza is influenced by various factors, including lower vitamin D levels due to less sunlight, lower humidity, lower temperature, and minor changes in virus proteins caused by antigenic drift. Despite the high number of infections, the reported number of influenza cases is usually much lower than the actual number, as many cases go unreported or are misdiagnosed. During seasonal epidemics, it is estimated that about 80 percent of otherwise healthy adults who have fever and a cough have the flu, and approximately 30 to 40 percent of people hospitalized for influenza develop pneumonia. The mortality rate is concentrated in the very young and the elderly, but during flu pandemics, young adults are often affected at a high rate, as seen in the 1918 Spanish flu pandemic. The economic and social impact of influenza is also significant, with people missing work or school and experiencing decreased job performance and reduced independence in older adults.
The History of a Hidden Enemy
The first convincing record of an influenza pandemic dates back to 1510, beginning in East Asia before spreading to North Africa and then Europe, but whether earlier epidemics were caused by influenza remains unclear due to the lack of consistent naming patterns for epidemic respiratory diseases. The first flu pandemic of the 18th century started in 1729 in Russia in spring, spreading worldwide over the course of three years with distinct waves, the later ones being more lethal. The 1889 pandemic, which may have been caused by an H2N2 strain, marked the point at which influenza had become an easily recognizable disease, and the microbial agent responsible was incorrectly identified in 1892 by R. F. J. Pfeiffer as the bacteria species Haemophilus influenzae, which retains influenza in its name. The fundamental differences between viruses and bacteria were not fully understood until 1901 to 1903, when Italian and Austrian researchers showed that avian influenza, then called fowl plague, was caused by a microscopic agent smaller than bacteria. The first influenza vaccine was licensed in 1945 in the United States, and influenza A virus was identified as the agent responsible for human influenza in 1933. Four influenza pandemics have occurred since World War II, including the Asian flu in 1957, the Hong Kong flu in 1968, the Russian flu in 1977, and the swine flu pandemic in 2009. Each pandemic has left a lasting impact on global health, leading to the development of surveillance systems, vaccines, and antiviral drugs to prevent and treat future outbreaks.
The Battle for Survival
Influenza can be prevented and treated through a combination of vaccination, antiviral drugs, and non-pharmaceutical interventions, but the effectiveness of these measures depends on the timing and the specific strain of the virus. Annual vaccination is the primary and most effective way to prevent influenza and influenza-associated complications, especially for high-risk groups, with vaccines providing protection against an H1N1 strain, an H3N2 strain, and one or two influenza B virus strains. Antiviral drugs such as oseltamivir and zanamivir are primarily used to treat severely ill patients, especially those with compromised immune systems, and are most effective when started in the first 48 hours after symptoms appear. Non-pharmaceutical interventions, including hand washing, covering coughs and sneezes, and wearing masks, are essential to reduce transmission and spread, especially when vaccines and antiviral medications are limited. The lack of controlled studies and rigorous evidence of the effectiveness of some measures has hampered planning decisions and recommendations, but strategies endorsed by experts for all phases of flu outbreaks include hand and respiratory hygiene, self-isolation by symptomatic individuals, and contact tracing. The role of genetics in influenza is not well researched, but it may be a factor in influenza mortality, and the future of flu pandemics, which may be caused by an influenza virus of avian origin, is viewed as almost inevitable due to increased globalization.